Evidence map›Paper›PMID 39065659›Full record

ArticlePharmaceutics2024

Liposomal Encapsulation of Ascorbyl Palmitate: Influence on Skin Performance.

Aleksandra Stolić Jovanović, Vanja M Tadić, Milica Martinović, Ana Žugić, Ivana Nešić, Stevan Blagojević, Nebojša Jasnić, Tomislav Tosti

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aleksandra Stolić Jovanović"Filly Farm" Pharmacy, Miloša Velikog bb, 11320 Velika Plana, Serbia.
Vanja M TadićDepartment for Pharmaceutical Research and Development, Institute for Medicinal Plant Research "Dr. Josif Pančić", Tadeuša Koscuška 1, 11000 Belgrade, Serbia.ORCID 0000-0003-1761-604X
Milica MartinovićDepartment of Pharmacy, Faculty of Medicine, University of Nis, Boulevard Dr. Zorana Djindjića 81, 18000 Nis, Serbia.ORCID 0000-0002-3648-5631
Ana ŽugićDepartment for Pharmaceutical Research and Development, Institute for Medicinal Plant Research "Dr. Josif Pančić", Tadeuša Koscuška 1, 11000 Belgrade, Serbia.
Ivana NešićDepartment of Pharmacy, Faculty of Medicine, University of Nis, Boulevard Dr. Zorana Djindjića 81, 18000 Nis, Serbia.
Stevan BlagojevićThe Institute of General and Physical Chemistry, Studentski trg 12/V, 11158 Beograd, Serbia.
Nebojša JasnićFaculty of Biology, University of Belgrade, Studentski trg 16, 11158 Beograd, Serbia.ORCID 0000-0003-0333-333X
Tomislav TostiInstitute of Chemistry, Technology and Metallurgy-National Institute of the Republic of Serbia, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0002-1403-4688

Funding

Ministry of Science, Technological Development and Innovations of the Republic of Serbia E! 17236 NATBIOPREP
6 · The paper itself

Abstract

L-ascorbic acid represents one of the most potent antioxidant, photoprotective, anti-aging, and anti-pigmentation cosmeceutical agents, with a good safety profile. However, the main challenge is the formulation of stable topical formulation products, which would optimize the penetrability of L-ascorbic acid through the skin. The aim of our research was to evaluate the performance of ascorbyl palmitate on the skin, incorporated in creams and emulgels (2%) as carriers, as well as to determine the impact of its incorporation into liposomes on the penetration profile of this ingredient. Tape stripping was used to study the penetration of ascorbyl palmitate into the stratum corneum. In addition, the sensory and textural properties of the formulations were determined. The liposomal formulations exhibited a better penetration profile (

Indexed as

ascorbyl palmitatecreamemulgelliposomestape stripping

Identifiers

PMID39065659
PMCPMC11280113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.